Copyright
©The Author(s) 2023.
World J Hepatol. Jun 27, 2023; 15(6): 813-825
Published online Jun 27, 2023. doi: 10.4254/wjh.v15.i6.813
Published online Jun 27, 2023. doi: 10.4254/wjh.v15.i6.813
Figure 1 Flow-chart of the Study.
NHANE III: The National Health and Nutrition Examination Survey III (1988-1994); HBsAg: Hepatitis B surface antigen; HCV: Hepatitis C virus; BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; TC: Total cholesterol; TG: Triglyceride; HDL: High-density lipoprotein cholesterol; FPG: Fasting plasma glucose; HbA1c: Glycosylated hemoglobin; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; NAFLD: Nonalcoholic fatty liver disease.
- Citation: Zheng JR, Wang ZL, Jiang SZ, Chen HS, Feng B. Lower alanine aminotransferase levels are associated with increased all-cause and cardiovascular mortality in nonalcoholic fatty liver patients. World J Hepatol 2023; 15(6): 813-825
- URL: https://www.wjgnet.com/1948-5182/full/v15/i6/813.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i6.813